Aptiv EVP sells 3,000 shares in planned trade
Aptiv PLC executive Obed D. Louissaint reported an open-market sale of 3,000 Ordinary Shares at $69.60 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aptiv PLC executive Obed D. Louissaint reported an open-market sale of 3,000 Ordinary Shares at $69.60 per share. The transaction took place on June 15, 2026, and was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.
Following this sale, Louissaint directly holds 210,803 Aptiv Ordinary Shares, indicating he retains a substantial ongoing equity stake in the company despite the disposition.
Insights
Executive sold 3,000 shares under a pre-set 10b5-1 plan while keeping a large remaining stake.
The filing shows EVP & Chief People Officer Obed D. Louissaint conducted an open-market sale of 3,000 Aptiv Ordinary Shares at $69.60 per share on June 15, 2026. After this trade, he directly holds 210,803 shares.
The footnote states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans are pre-arranged, reducing the informational value of the trade’s timing and suggesting it is part of routine portfolio or liquidity management.
No derivative exercises or tax-withholding entries appear in this filing, and the remaining share position is much larger than the amount sold. This points to a modest, planned sale rather than a significant shift in his exposure to Aptiv equity.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 3,000 | $69.60 | $209K |
Footnotes (1)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Aptiv (APTV) disclose for Obed D. Louissaint?
Was the Aptiv (APTV) insider sale under a Rule 10b5-1 trading plan?
Does the Aptiv (APTV) Form 4 show any option exercises or derivative trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.